About Emily Minkow
Emily Minkow is a managing director at RA Capital Management and a director of Estuary Biotherapeutics. Estuary develops gene therapies for serious kidney diseases.
She became Prevail Therapeutics' executive vice president of business development and strategy in 2017 and chief business officer in 2018. Before Prevail, she worked at Celgene from 2010 to 2017, most recently as executive director of business development. Her other Celgene roles included principal to the chairman and CEO and director of global marketing. Earlier, she advised biotechnology and pharmaceutical companies as a consultant at Frankel Group.
Experience
This experience comes from official bios, from Emily Minkow's profile and from SEC filings. For roles taken from filings, the years are when the filings name Emily Minkow in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Emily Minkow works with at each company, as listed on that company's latest Form D.